Literature DB >> 12234254

Malaria vaccine: candidate antigens, mechanisms, constraints and prospects.

L J M Carvalho1, C T Daniel-Ribeiro, H Goto.   

Abstract

More than 30 years after the first report of successful vaccination against malaria using radiation-attenuated sporozoites, an effective malaria vaccine is not yet available. However, field and experimental data indicate that it can be developed. An astonishing amount of data has accumulated concerning parasite biology, host-parasite interactions, immunity and escape mechanisms, targets and modulators of immune responses. Nevertheless, so far this knowledge has not been enough to make us understand how to properly manipulate the whole system to build an effective vaccine. In this article, we describe candidate antigens, mechanisms, targets and trials performed with potential malaria vaccines and discuss the approaches, in vivo and in vitro models, constraints and how technologies such as DNA vaccination, genomics/proteomics and reverse immunogenetics are providing exciting results and opening new doors to make malaria vaccine a reality.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234254     DOI: 10.1046/j.1365-3083.2002.01160.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  24 in total

1.  Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum erythrocyte binding ligand 1 (EBL-1)-derived peptides.

Authors:  Hernando Curtidor; Luis E Rodríguez; Marisol Ocampo; Ramses López; Javier E García; John Valbuena; Ricardo Vera; Alvaro Puentes; Magnolia Vanegas; Manuel E Patarroyo
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

2.  Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1.

Authors:  Ariane Rodríguez; Jaap Goudsmit; Arjen Companjen; Ratna Mintardjo; Gert Gillissen; Dennis Tax; Jeroen Sijtsma; Gerrit Jan Weverling; Lennart Holterman; David E Lanar; Menzo J E Havenga; Katarina Radosevic
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

3.  Complete nucleotide sequences of the mitochondrial genomes of two avian malaria protozoa, Plasmodium gallinaceum and Plasmodium juxtanucleare.

Authors:  Sumie Omori; Yukita Sato; Takashi Isobe; Masayoshi Yukawa; Koichi Murata
Journal:  Parasitol Res       Date:  2006-10-18       Impact factor: 2.289

4.  Immunological evaluation of two novel engineered Plasmodium vivax circumsporozoite proteins formulated with different human-compatible vaccine adjuvants in C57BL/6 mice.

Authors:  Samaneh H Shabani; Sedigheh Zakeri; Yousef Mortazavi; Akram A Mehrizi
Journal:  Med Microbiol Immunol       Date:  2019-04-25       Impact factor: 3.402

5.  Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaA.

Authors:  Can Xu; Zhao-Shen Li; Yi-Qi Du; Zhen-Xing Tu; Yan-Fang Gong; Jing Jin; Hong-Yu Wu; Guo-Ming Xu
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

6.  Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2.

Authors:  Can Xu; Zhao-Shen Li; Yi-Qi Du; Yan-Fang Gong; Hua Yang; Bo Sun; Jing Jin
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

7.  The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert.

Authors:  Katarina Radosevic; Ariane Rodriguez; Angelique A C Lemckert; Marjolein van der Meer; Gert Gillissen; Carolien Warnar; Rie von Eyben; Maria Grazia Pau; Jaap Goudsmit
Journal:  Clin Vaccine Immunol       Date:  2010-09-08

8.  Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants.

Authors:  Leonardo J M Carvalho; Francisco A Alves; Cesare Bianco; Salma G Oliveira; Graziela M Zanini; Soe Soe; Pierre Druilhe; Michael Theisen; José A P C Muniz; Cláudio T Daniel-Ribeiro
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

9.  A genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites.

Authors:  Axel Martinelli; Sandra Cheesman; Paul Hunt; Richard Culleton; Ahmed Raza; Margaret Mackinnon; Richard Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-07       Impact factor: 11.205

10.  Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies.

Authors:  Charlotte Joos; Laurence Marrama; Hannah E J Polson; Sandra Corre; Antoine-Marie Diatta; Babacar Diouf; Jean-François Trape; Adama Tall; Shirley Longacre; Ronald Perraut
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.